Alkermes Plc (NASDAQ:ALKS)
| 19.69 Delayed Data As of Jul 10 |  -0.35 / -1.75%Today’s Change | 11.98 Today|||52-Week Range 25.35 | -3.48% Year-to-Date |
Latest ALKS News | Press Releases
No recent news for Alkermes Plc.
Today’s Trading
| Previous close | 20.04 |
| Today’s open | 19.85 |
| Day’s range | 19.48 - 20.06 |
| Volume | 58,795 |
| Average volume (3 months) | 1,733,861 |
| Market cap | $3.1B |
Data as of 3:59pm ET, 07/10/2020
Growth & Valuation
| Earnings growth (last year) | -39.39% |
| Earnings growth (this year) | -89.30% |
| Earnings growth (next 5 years) | +2.67% |
| Revenue growth (last year) | +7.01% |
| P/E ratio | NM |
| Price/Sales | 2.74 |
| Price/Book | 2.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ALLKAllakos Inc | +1.30 | +1.94% |
| TGTXTG Therapeutics Inc | -0.47 | -1.95% |
| INSMInsmed Inc | -0.12 | -0.43% |
| PTCTPTC Therapeutics Inc | -1.88 | -3.31% |
Data as of 4:00pm ET, 07/10/2020
Financials
| Next reporting date | July 23, 2020 |
| EPS forecast (this quarter) | -$0.00 |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | -$196.6M |
| Net profit margin | -16.79% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Dublin, Dublin |
Forecasts
